Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description adds substantial behavior beyond the read-only/idempotent annotations: it discloses ambiguity handling via figi_candidates, explicit unresolved identifier reporting, graceful degradation when GLEIF/OpenFIGI are unavailable, internal cascading lookups, and cross-source identity resolution. No contradiction with the annotations exists.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, but nearly every clause earns its place given the tool's complexity and the breadth of entity types and fallbacks. It is front-loaded with usage intent and the 'USE FIRST' directive; the main weakness is run-on parenthetical structure that could be organized more cleanly.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description compensates by enumerating the key returns: CIK, ticker, company name, LEI, ownership, FIGI, unresolved identifiers, RxCUI, ingredient, brand, and citation. It also covers input variants, edge cases, and failure behavior, making the tool self-sufficient for an agent to select and invoke correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Even though the schema already documents both parameters well, the description adds meaningful semantic detail: it introduces ISIN as an accepted company input beyond the schema's ticker/CIK/name list, explains what each type resolves to, and clarifies that the value must be the entity name only, not the full noun phrase. This goes well beyond the baseline for high schema coverage.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete natural-language queries and states the core action: resolve a user-spoken NAME to canonical/official identifiers other tools require as input. It names the two supported entity types and clarifies its role relative to downstream tools, making the tool's purpose unmistakable.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives an explicit trigger: 'Use FIRST whenever you have a name but need an ID.' It also illustrates many invocation scenarios. It does not explicitly say when not to use it or name sibling tools like entity_profile as alternatives, so it stops short of a full when/when-not contrast.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation3/5

Many tools have overlapping purposes (e.g., multiple Polymarket tools, multiple company information tools), but descriptions help distinguish them. However, the variety of domains (brand monitoring, betting, package scanning, memory, etc.) can confuse an agent.

Naming Consistency2/5

Tool names have no consistent naming pattern: some are verb_noun (validate_claim), some are noun_verb (bet_research), some are compound (ai_visibility_check), and some are single word (forget). This makes it hard to predict tool names.

Tool Count2/5

28 tools is high, and the set spans many unrelated domains (brand visibility, SEC/FDA data, Polymarket, npm packages, memory, etc.) while the server is named 'Expression Atlas' with only 2 tools related to that purpose. The tool count feels excessive and unfocused.

Completeness1/5

For a server named 'Expression Atlas', only two tools (get_experiment, search_experiments) cover the domain. There are no tools for submitting, updating, or deleting experiments, nor any for data visualization. The surface is severely incomplete.